Evidence map›Paper›PMID 20456288›Full record

ReviewAddiction biology2010

Cognitive effects of nicotine: genetic moderators.

Aryeh I Herman, Mehmet Sofuoglu

Abstract readReview
In one paragraph

Review in Addiction biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Nicotine supplementation enhances simulated game performance of archery athletes.Journal of the International Society of Sports Nutrition · 2021
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Testing Association of Previously Implicated Gene Sets and Gene-Networks in Nicotine Exposed Mouse Models with Human Smoking Phenotypes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cigarette Smoking and Tryptophan Hydroxylase 2 mRNA in the Dorsal Raphe Nucleus in Suicides.Archives of suicide research : official journal of the International Academy for Suicide Research · 2016
    Article
  12. Article
  13. [Neuroenhancement].Der Nervenarzt · 2014
    Review
  14. Article
  15. Review
  16. Depressive symptoms among heavy cigarette smokers: the influence of daily rate, gender, and race.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Article
  17. Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aryeh I HermanDepartment of Psychiatry and VA Connecticut Healthcare System, School of Medicine, Yale University, West Haven, CT 06516, USA.
Mehmet Sofuoglu
VA Connecticut Healthcare System · US

Funding

SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Human Laboratory Studies for Stimulant AddictionK02DA021304 · NIDA · YALE UNIVERSITY · PI SOFUOGLU, MEHMET · 2008 to 2011
$460k
NIDA NIH HHS K02 DA021304NIDA NIH HHS K12 DA000167NIDA NIH HHS K12 DA00167
6 · The paper itself

Abstract

Cigarette smoking is the main preventable cause of death in developed countries, and the development of more effective treatments is necessary. Cumulating evidence suggests that cognitive enhancement may contribute to the addictive actions of nicotine. Several studies have demonstrated that nicotine enhances cognitive performance in both smokers and non-smokers. Genetic studies support the role of both dopamine (DA) and nicotinic acetylcholine receptors (nAChRs) associated with nicotine-induced cognitive enhancement. Based on knockout mice studies, beta2 nAChRs are thought to be essential in mediating the cognitive effects of nicotine. alpha7nAChRs are associated with attentional and sensory filtering response, especially in schizophrenic individuals. Genetic variation in D2 type DA receptors and the catechol-O-methyltransferase enzyme appears to moderate cognitive deficits induced by smoking abstinence. Serotonin transporter (5-HTT) gene variation also moderates nicotine-induced improvement in spatial working memory. Less is known about the contribution of genetic variation in DA transporter and D4 type DA receptor genetic variation on the cognitive effects of nicotine. Future research will provide a clearer understanding of the mechanism underlying the cognitive-enhancing actions of nicotine.

Indexed as

AnimalsBrainCatechol O-MethyltransferaseCognitionHumansMemory, Short-TermMiceMice, KnockoutNicotineReceptors, DopamineReceptors, NicotinicSchizophreniaSerotonin Plasma Membrane Transport ProteinsSmokingTobacco Use DisorderCatechol O-MethyltransferaseNicotineReceptors, DopamineReceptors, NicotinicSerotonin Plasma Membrane Transport Proteins

Identifiers

PMID20456288
PMCPMC2903639
OpenAlexW2104085668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.